Riskpilot← Back to searchSign inGet full accessBalt Nordics AB
ABActiveOrg 5565661252Drakegatan 7 BWholesale of pharmaceutical and medical goods · NACE 4646Est. 19998 employees
Revenue 2025
SEK 59,4M
+11% vs 2024
EBITDA margin
6.1%
-12% vs 2024
Equity ratio
68.8%
Financial strength
Net profit 2025
SEK 2,6M
-14% vs 2024
| Revenue | SEK 59,4M | +11% |
| EBITDA | SEK 3,6M | -12% |
| Net profit | SEK 2,6M | -14% |
| Total assets | SEK 30,7M | +10% |
| Equity | SEK 21,1M | +14% |
| Employees | 8 | — |
Legal name
Balt Nordics AB
Org number
5565661252
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12 februari 1999
Share capital
SEK 100 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Föremålet för bolagets verksamhet är att bedriva import, utveckling och försäljning av produkter inom sjukvårdssektorn, distrubution av medicinteknisk utrustning samt därmed förenlig verksamhet.
Address
Drakegatan 7 B
Email
infonordics@baltgroup.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 31 695 | 37 891 | 47 137 | 53 600 | 59 353 |
| Staff expenses | — | −8 786 | −8 814 | −10 312 | −13 346 |
| EBITDA | 4 344 | 3 639 | 3 351 | 4 107 | 3 603 |
| Depreciation & amort. | −72 | −133 | −133 | −229 | −235 |
| EBIT | 4 272 | 3 506 | 3 219 | 3 878 | 3 368 |
| Net financials | −2 | −3 | −25 | −2 | 37 |
| Profit before tax | 4 270 | 3 504 | 3 194 | 3 876 | 3 405 |
| Tax | −895 | −743 | −699 | −821 | −790 |
| Net profit | 3 375 | 2 760 | 2 495 | 3 055 | 2 615 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 19 697 | 22 605 | 27 091 | 27 978 | 30 707 |
| Equity | 13 202 | 15 962 | 18 458 | 18 513 | 21 127 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 6 495 | 6 643 | 8 633 | 9 465 | 9 580 |
| Total debt | 6 495 | 6 643 | 8 633 | 9 465 | 9 580 |
EBITDA margin
6.1%
This company
15.8%
Market median
-61% vs market
20212025
Equity ratio
68.8%
This company
38.2%
Market median
+80% vs market
20212025
Return on equity
12.4%
This company
18.4%
Market median
+33% vs market
20212025
Net profit margin
4.4%
This company
8.1%
Market median
-46% vs market
20212025
Asset turnover
1.93×
This company
1.12×
Market median
+72% vs market
20212025
Debt / equity
0.45×
This company
0.62×
Market median
+27% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
DM Chief Executive Officer | Chief Executive Officer | 2022 |
MP | Audit | 2021 |
| Former (1) | ||
KA Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Balt Nordics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Diana Mårdbrink | Chief Executive Officer | 0 companies |
| Karl Anders Stefan Nordin | Chief Executive Officer | 0 companies |
| Maj Pernilla Hee Ja Rex | Audit | 0 companies |
| Bruno Charles Galie | Chairman | 0 companies |
| Emeric Marie Etienne Domergue | Board of Directors | 0 companies |